17/03/2023, Thứ sáu
In a recently published study, researchers from the Cancer Science Institute of Singapore (CSI Singapore) at NUS demonstrated for the first time the mechanism that causes the suppression of the RNA editing enzyme known as adenosine deaminases acting on RNA (ADAR2). The NUS researchers also show how understanding this mechanism can explain the development of CBF-AML.